Text Size

Genomic Analysis of Pediatric Bone Tumors

This study is currently recruiting participants.
Verified December 2012 by Stanford University
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01047878
First received: January 11, 2010
Last updated: December 11, 2012
Last verified: December 2012
History of Changes

January 11, 2010
December 11, 2012
August 2007
August 2014   (final data collection date for primary outcome measure)
  • % necrosis post chemotherapy [ Time Frame: his is measured at the time of sample collection since we are looking for % necrosis in the sample we are collecting ] [ Designated as safety issue: No ]
  • overall survival and event free survival [ Time Frame: This is measured at the time the patient dies, or at the time when patient relapses from their disease. There is no set time since this outcome is individually assessed. ] [ Designated as safety issue: No ]
  • % necrosis post chemotherapy [ Time Frame: This is measured at the time of sample collection since we are looking for % necrosis in the sample we are collecting ] [ Designated as safety issue: No ]
  • overall survival and event free survival [ Time Frame: This is measured at the time the patient dies, or at the time when patient relapses from their disease. There is no set time since this outcome is individually assessed. ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT01047878 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Genomic Analysis of Pediatric Bone Tumors
Genomic Analysis of Pediatric Bone Tumors (Other Title: Pediatric Bone Tumor Biology Study)

To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

tumor samples and blood
Non-Probability Sample

All patients with bone x-rays suggestive of a malignant bone tumor
Bone Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
150
August 2016
August 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:All patients with bone x-rays suggestive of a malignant bone tumor

Exclusion Criteria:Patients with a known diagnosis of cancer.
Both
up to 18 Years
No
Contact: Lolita Penland (650) 736-2753 lpenland@stanford.edu
United States
 
NCT01047878
PEDSSARC0001, 97630, SU-12082009-4522
Not Provided
Stanford University
Stanford University
Not Provided
Principal Investigator: Dr. Alejandro Sweet-Cordero Stanford University
Stanford University
December 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP